Literature DB >> 3244655

Determination of the pH-dependent phase distribution of prostaglandin E1 in a lipid emulsion by ultrafiltration.

D L Teagarden1, B D Anderson, W J Petre.   

Abstract

The distribution of prostaglandin E1 (PGE1) in a lipid emulsion has been shown to be consistent with a three-phase model which assumes that solute may reside in the bulk aqueous and oil phases and at the oil/water interface. Calculations suggest that, in a lipid emulsion having an average particle size of 0.11 micron, it is theoretically possible for a surface active species such as PGE1 to exist predominantly at the interface. Aqueous phase concentrations of PGE1 versus pH were measured in an emulsion having an oil/water phase volume ratio of 0.1 by the use of an ultrafiltration technique in order to estimate the relative percentages of PGE1 in each phase. From bulk oil/water partition coefficient determinations, the amount of PGE1 present in the bulk oil phase of the emulsion was concluded to be insignificant. At emulsion pH values less than 5, PGE1 resides preferentially (greater than 97%) at the interface. With increasing pH's, the percentage of PGE1 in the aqueous phase increases, reaching 51% at high pH's. A model which assumes that both the nonionized and the ionized PGE1 species may be present at the interface, depending on the pH, was shown to be consistent with the data. Estimates were made of the distribution coefficients of the ionized and nonionized PGE1 between the interface and the aqueous phase and their concentration dependence. The apparent pKa of PGE1 at the interface derived from these data was 6.8. The distribution coefficients were used to generate a distribution profile of the various PGE1 species as a function of the pH. This distribution profile will be useful in explaining kinetic data of PGE1 in the emulsion as a function of pH.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3244655     DOI: 10.1023/a:1015961122982

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  6 in total

1.  Physical studies of aqueous solutions of two prostaglandins.

Authors:  M C Johnson; L Saunders
Journal:  Biochim Biophys Acta       Date:  1970-12-15

2.  Anti-inflammatory effects of indomethacin ester incorporated in a lipid microsphere.

Authors:  Y Mizushima; Y Wada; Y Etoh; K Watanabe
Journal:  J Pharm Pharmacol       Date:  1983-06       Impact factor: 3.765

3.  Prostaglandin E1 is more effective, when incorporated in lipid microspheres, for treatment of peripheral vascular diseases in man.

Authors:  Y Mizushima; A Yanagawa; K Hoshi
Journal:  J Pharm Pharmacol       Date:  1983-10       Impact factor: 3.765

4.  Lipid microspheres as novel drug carriers.

Authors:  Y Mizushima
Journal:  Drugs Exp Clin Res       Date:  1985

5.  Prostaglandin E1 incorporated in lipid microspheres (lipo PGE1).

Authors:  S Otomo; Y Mizushima; H Aihara; K Yokoyama; M Watanabe; A Yanagawa
Journal:  Drugs Exp Clin Res       Date:  1985

6.  Prostaglandin E1 incorporated in lipid microspheres in the treatment of peripheral vascular diseases and diabetic neuropathy.

Authors:  K Hoshi; Y Mizushima; S Kiyokawa; A Yanagawa
Journal:  Drugs Exp Clin Res       Date:  1986
  6 in total
  5 in total

1.  Entrapping efficiency and drug release profile of an oil-in-water (o/w) emulsion formulation using a polydimethylsiloxane-coated glass bead assay.

Authors:  T Minagawa; Y Kohno; T Suwa; A Tsuji
Journal:  Pharm Res       Date:  1994-04       Impact factor: 4.200

2.  Dehydration kinetics of prostaglandin E1 in a lipid emulsion.

Authors:  D L Teagarden; B D Anderson; W J Petre
Journal:  Pharm Res       Date:  1989-03       Impact factor: 4.200

3.  Elimination of the biphasic pharmacodynamics of 15d-PGJ2 by controlling its release from a nanoemulsion.

Authors:  Saed Abbasi; Kazuaki Kajimoto; Hideyoshi Harashima
Journal:  Int J Nanomedicine       Date:  2016-06-08

4.  Theranostic combinatorial drug-loaded coated cubosomes for enhanced targeting and efficacy against cancer cells.

Authors:  Leilei Zhang; Jinlong Li; Dan Tian; Lihua Sun; Xu Wang; Miao Tian
Journal:  Cell Death Dis       Date:  2020-01-02       Impact factor: 8.469

5.  In vitro and in vivo evaluation of cubosomes containing 5-fluorouracil for liver targeting.

Authors:  Mohamed Nasr; Mohamed K Ghorab; Ahmed Abdelazem
Journal:  Acta Pharm Sin B       Date:  2014-12-29       Impact factor: 11.413

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.